WO2026093929 - CYCLIN-DEPENDENT KINASE INHIBITORS
National phase entry is expected:
Publication Number
WO/2026/093929
Publication Date
07.05.2026
International Application No.
PCT/IB2025/061004
International Filing Date
29.10.2025
Title **
[English]
CYCLIN-DEPENDENT KINASE INHIBITORS
[French]
INHIBITEURS DE KINASE DÉPENDANTE DE LA CYCLINE
Applicants **
NOVARTIS AG
Inventors
CHEN, Xin
JOSEPH, Sajan
PFISTER, Keith Bruce
RAUNIYAR, Vivek
WU, Xiaoyun
Priority Data
24210312.5
31.10.2024
EP
25152482.3
17.01.2025
EP
25180272.4
02.06.2025
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5694 | |
| EPO | Filing, Examination, Granting | 42189 | |
| Japan | Filing, Examination, Granting | 3460 | |
| South Korea | Filing, Examination, Granting | 4525 | |
| USA | Filing, Examination, Granting | 17190 |
Total:
73,058
Contact Us
Abstract[English]
The invention relates to compounds which inhibit CDK4 (Cyclin-Dependent Kinase 4 or Cell Division protein Kinase 4), and to processes for the preparation of said compounds, pharmaceutical compositions comprising said compounds, and use of said compounds in the treatment of conditions, diseases and disorders mediated by CDK4.[French]
L'invention concerne des composés qui inhibent CDK4 (kinase dépendante de la cycline 4 ou la protéine kinase 4 de division cellulaire), et des procédés de préparation desdits composés, des compositions pharmaceutiques comprenant lesdits composés, et l'utilisation desdits composés dans le traitement d'états, de maladies et de troubles médiés par CDK4.